COMPANY PROFILE / #979
AQEMIA
Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. The company's platform combines machine learning and quantum-inspired statistical mechanics algorithms to generate lead-like molecules for a given target, enabling researchers to efficiently and accurately predict the affinity between drug candidates and therapeutic targets.Privately Held (backing)
已融资85
最新估值—
员工数—
成立年份insitro, Exscientia, AbCellera Biologics, Relay Therapeutics, Ariana Pharma, BenevolentAI, Recursion Pharmaceuticals, Schrodinger, InSilico Medicine Cayman
公司概况
- Companies
- AQEMIA
- Description
- —
- Website
- Paris, France
- HQ Location
- Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. The company's platform combines machine learning and quantum-inspired statistical mechanics algorithms to generate lead-like molecules for a given target, enabling researchers to efficiently and accurately predict the affinity between drug candidates and therapeutic targets.
- Year Founded
- insitro, Exscientia, AbCellera Biologics, Relay Therapeutics, Ariana Pharma, BenevolentAI, Recursion Pharmaceuticals, Schrodinger, InSilico Medicine Cayman
- Keywords
- 2026: 85, 2025: 79, 2024: 60, 2023: 48, 2022: 35, 2021: 15, 2020: 7, 2019: 2
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 85
- First Financing Date
- —
- First Financing Size
- 98
- First Financing Valuation
- —
- Last Financing Date
- 1.10%
- Last Financing Deal Type
- 01-Apr-2025
- Last Financing Size
- Grant
- Last Financing Valuation
- —
- Last Financing Status
- —
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- —
- Valuation Estimate
- 10-Dec-2024
- Valuation Estimate Growth Rate
- ai-powered drug discovery, computational chemistry, drug discovery company, drug molecules, small molecule, therapeutic model
- Active Investors
- Venture Capital-Backed
- # Active Investors
- 10%
- Acquirers
- Agoranov, BioIndustry Association, Bpifrance, C Entrepreneurs, Cathay Capital, Cathay Innovation, Deeptech Founders, Elaia Partners, Eurazeo, Idinvest Partners, La French Tech, Neighborhood, Sanofi, Wendel Group
团队与联系人
- Employees
- —
- Employee Growth %
- 2019
- Employee History
- —
- Primary Contact
- 69.47
- Primary Contact Title
- —
- Primary Contact Email
- Maximilien Levesque
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 80.18%
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- 466
- Size Multiple
- —
- Size Multiple % Change
- 243.62
- Size Multiple Change
- 0.13%
- Size Multiple Percentile
- 0.02x
- Majestic Referring Domains
- 14.27x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- 01-Jan-2019
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 26%
- Success Probability Over Time – 3 Year
- 41%
- Success Probability Over Time – 5 Year
- Co-Founder, Chief Executive Officer, President & Board Member
记录来源：public.companies · 原始序号 #979 · 所有字段均按数据库原值展示。